Jim Cramer has some thoughts on merger Monday.
On Monday, there were a handful of deals announced.
(LVMUY) is officially buying Tiffany's
(TIF) - Get Report for around $135 a share, which puts the deal at around $16.2 billion.
And then Charles Schwab
(SCHW) - Get Report officially announced that it was officially buying TD Ameritrade
(AMTD) - Get Report for around $26 billion.
Then there's also Novartis AG
(NVS) - Get Report buying Medicines Co.
(MDCO) - Get Report for around $85 a share, for a total of $9.7 billion.
So, what do these deals all have in common? Cramer said there's one thing: technology.
"Technology and how it's driving so many of these hot deals. Robin Hood wipes out the margins for Ameritrade, so Ameritrade gets bought by Schwab, they had to do it. Tiffany wasn't able to do customer relations management the scale that you need to do...when you see the technology of what a cholesterol drug that Novartis bought with Medicine Co...Cause it only has to be taken twice a year, which is fantastic," said Cramer.
More from Cramer Today
Full Replay: It's Merger Monday: Jim Cramer on Charles Schwab, TD Ameritrade, LVMH, Tiffany
Jim Cramer: How LVMH Buying Tiffany's Can Give the Jeweler its Sparkle Back
Jim Cramer on Charles Schwab Buying TD Ameritrade
Why Jim Cramer Thinks Facebook Could Be a Big Winner in the 2020 Election
Bull Market Fantasy: LIVE TUESDAY & THURSDAY @10:45AM
Subscribe to our Youtube Channel for more videos : Listen our latest Podcasts on Soundcloud
Catch Up: Today's Top News Videos Below